The most informative RCTs had been the ones that compared a cannabis‐based medication with a traditional anti‐emetic, somewhat than placebo. These trials confirmed that cannabis‐based medications had related anti‐emetic results compared with prochlorperazine and metoclopramide. Overall, the trials had been of variable high quality (very low to average by Grading of Recommendations Assessment,